cardiomyopathy
NHGRI to Fund Population Genomic Screening in Primary Care Network With $38.1M
Starting next year, the network will implement a population genomic screening pilot program for common, actionable genomic conditions in a primary care setting over five years.
Genetic Architecture for Comorbid Depression, Coronary Artery Disease Emerges from Study
Genetic and electronic health record analyses suggest patients with both coronary artery disease and depression share variants in genes involved in inflammatory and cardiomyopathy processes.
Increase in Healthcare Utilization, Costs Modest After Genetic Risk Results Return
Researchers tracked follow-up healthcare use and cost in the 12 months after individuals and providers received pathogenic or likely pathogenic variant results for five conditions.
BabySeq Project Unearths Actionable Genetic Variants Impacting Infants, Parents
Researchers saw monogenic disease-related mutations in almost 11 percent of infants' genomes, prompting further testing and management, including for family members.
Expanded Genetic Testing Leads to Additional Cardiomyopathy, Arrhythmia Diagnoses
Researchers estimated that more than 10 percent of positive results would have been missed had testing been based on clinician-provided diagnostic indications.